Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Full development adverse events

The enteric use of perflubron has been studied and the authors concluded that it is relatively safe and effective. The main adverse effects were vomiting, which developed in 8% of patients, and a feehng of fullness reported in 5% of cases. Other adverse events involved complaints about the taste of the agent. There were no life-threatening or fatal events (SEDA-21, 484). [Pg.3544]

A focal point for critical care pharmacists and hospitals with critical care units is a position paper on critical care pharmacy services jointly developed and published by ACCP and SCCM. - This paper identifies and describes the fundamental, desirable, and optimal activities that define the scope of practice of the critical care pharmacist (Table 2 ). Fundamental activities are deemed vital to the safe provision of pharmaceutical care to the critically ill patient. The fundamental responsibilities of critical care pharmacists include a full-time commitment to critical care patients, evaluation of all drug therapy, identification of adverse events, individualized drug dosing, provision of drug information, documentation of activities, and... [Pg.237]

The patient safety program must include the development of a continuous assessment process to prevent error occurrence. Event information from data and incident occurrence reports should be reviewed by the multidisciplinary team to prioritize organizational efforts. Sources of data could include incident reports, medication errors, adverse drug reactions, transfusion reactions, sentinel events, and other adverse events. The patient safety program encompasses the patient population, visitors, volunteers, physicians, and staff and addresses improvement issues in every department. Senior leadership must be responsible for ensuring full implementation of the program, with an emphasis on the following functions ... [Pg.452]


See other pages where Full development adverse events is mentioned: [Pg.1335]    [Pg.112]    [Pg.157]    [Pg.522]    [Pg.63]    [Pg.3551]    [Pg.303]    [Pg.650]    [Pg.409]    [Pg.176]    [Pg.28]    [Pg.86]    [Pg.307]    [Pg.5]    [Pg.73]    [Pg.506]    [Pg.133]    [Pg.2192]    [Pg.153]    [Pg.3]   
See also in sourсe #XX -- [ Pg.398 ]




SEARCH



Adverse events

Full development

© 2024 chempedia.info